XML 57 R30.htm IDEA: XBRL DOCUMENT

Fair Value Measurements and Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Cash Equivalents and Short-term Investments

The following is a summary of the Company’s cash equivalents and short-term investments (in thousands):


			December 31, 2024
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
Level 1
Money market funds			$	165					$	—					$	—					$	165
Level 2
Commercial paper			78,500						10						(9)						78,501
U.S. government and agency securities			41,210						56						—						41,266
Total cash equivalents and short-term investments			119,875						66						(9)						119,932
Less: Cash equivalents			(54,901)						—						8						(54,893)
Total short-term investments			$	64,974					$	66					$	(1)					$	65,039


			December 31, 2023
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
Level 1
Money market funds			$	10,204					$	—					$	—					$	10,204
Level 2
Commercial paper			64,693						—						(35)						64,658
U.S. government and agency securities			17,616						4						(17)						17,603
Total cash equivalents and short-term investments			92,513						4						(52)						92,465
Less: Cash equivalents			(70,972)						—						33						(70,939)
Total short-term investments			$	21,541					$	4					$	(19)					$	21,526